<DOC>
	<DOC>NCT00864487</DOC>
	<brief_summary>The purpose of this study is to examine whether co-administration of rifampin with neratinib has an effect on the pharmacokinetics (how the body absorbs, distributes, metabolizes and/or excretes) of neratinib.</brief_summary>
	<brief_title>Study Evaluating The Potential Effect Of Rifampin On The Pharmacokinetics Of Neratinib</brief_title>
	<detailed_description />
	<mesh_term>Rifampin</mesh_term>
	<criteria>Inclusion criteria: Healthy men or women (of non childbearing potential) Ages 18 to 50 years old.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>May 2012</verification_date>
</DOC>